GSK plc
The VP Medicine Development Leader (MDL) is responsible for the global development of a medicine from clinical proof of concept through approval in major markets, acting as the single point of accountability. The role leads a cross‑functional Medicine Development Team, partners with early development, commercial, regulatory and manufacturing functions, and oversees budgeting, strategy, and post‑approval activities.
Headquarters
London, England, United Kingdom
Company Size
10001+ employees
Founded
1830
At GSK, we unite science, technology and talent to get ahead of disease together
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for GSK plc.
9% above the average for this role
GSK enters agreement with U.S. government to lower drug prices and expand access to respiratory medicines for millions of Americans
Dec 19, 2025
Vice President, Clinical Development
Tarsus Pharmaceuticals
Vice President, Clinical Development
Tarsus Pharmaceuticals
VP, Product Team Leader
Vividion Therapeutics
Executive Director, Experimental Medicine – Immunology
Digital Biology
ExploR&D Translational Medicine
lifelancer
VP/SVP, Head of Regulatory Affairs
Systimmune